INVESTORS CIRCLE AUSSIE PHARMA STOCK.
By: Stan Kipper.
Investors are watching on as the state of Victoria spirals out of control "In declaring a State of Disaster,Premier Daniel Andrews has conceded that his government has lost control of COVID-19 in this state.
The failings of the Labor Government in hotel quarantine, in testing and in contact tracing have led to millions of Victorians being subjected to the harshest restrictions in our history.
"Curfews. Businesses that will be closed. Limits on daily exercise. Limits on shopping. Limits on moving 5 kilometres from your home.
"Unprecedented in their nature and their intrusion into the lives of Victorians, but other states are at risk of a Covid explosion as well if a treatment isn’t released soon.
"These measures will be very costly in both economic and human terms. Victorians are being asked to make sacrifices like never before.
As the killer virus spreads investors wait on news from one promising Aussie junior, the right announcement could see its share price head for the heavens on release to world markets.
A repeat preliminary evaluation of PharmAust’s(ASX: PAA) lead cancer drug monepantel and monepantel sulfone has found it can reduce transmission in cells infected with the current SARS-CoV-2 strain of coronavirus.Replication of an invitro virus infectivity experiment carried out earlier this month has used the same median tissue culture infectious dose (TCID50) method and confirmed initial findings.The repeat experiments were conducted by virologists at Melbourne’s Walter and Eliza Hall Institute of Medical Research and again demonstrated thatinfectivity of SARS-CoV-2 virus particles can be suppressed by up to 95% in cell cultures treated with either monepantel or monepantel sulfone.
If successful PharmAust’s news will rocket around the globe on release rewarding its investors with very handy profits, some who have waited several years for a return now look forward to a once in not too often payday, but even short term investors will be rewarded handsomely.
(20min delay)